Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours
Clinical trial NCT01221246 · COMPLETED
Trial details
- NCT number
- NCT01221246
- Sponsor
- Genervon Biopharmaceuticals, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-08
- Primary completion
- 2016-07-07
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.